ArticleVirologica Sinica2020
Isolation and Growth Characteristics of SARS-CoV-2 in Vero Cell.
Abstract readLetterComment
In one paragraph
Article in Virologica Sinica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Development of a two-component recombinant vaccine for COVID-19.Frontiers in immunology · 2024Article
- Urticaria after breakthrough Omicron BA.5.1 severe acute respiratory syndrome coronavirus 2 infection in a triple-vaccinated (Pfizer) patient: a case report.Journal of medical case reports · 2023Article
- A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products.Regenerative medicine · 2023Review
- Comparative transcriptomic analyzes of human lung epithelial cells infected with wild-type SARS-CoV-2 and its variant with a 12-bp missing in the E gene.Frontiers in microbiology · 2022Article
- SARS-CoV-2 at the human-animal interphase: A review.Heliyon · 2021Review
- Article
- Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2.PLoS computational biology · 2021Article
- Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review.Transfusion · 2020Review
- A SARS-CoV-2 variant with the 12-bp deletion at E gene.Emerging microbes & infections · 2020Article
Corrections and comments
- Comment on
Authors and funding
25 authors.
Pingping YaoKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Yachun ZhangR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Yisheng SunKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Yulin GuR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Fang XuKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Bo SuR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Chen ChenKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Hangjing LuKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Dehui WangR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Zhangnv YangKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Biao NiuR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Jiancai ChenKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Lixia XieR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Lei ChenR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Yajing ZhangR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Hui WangR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Yuying ZhaoR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Yue GuoR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Juncheng RuanR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China.
Zhiyong ZhuKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China.
Zhenfang FuState Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China. zhenfu@uga.edu.ORCID http://orcid.org/0000-0001-6293-9329
Dayong TianR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China. tiandayong@king-cell.com.ORCID http://orcid.org/0000-0001-8978-8970
Qi AnR&D Department, Shanghai King-Cell Biotechnology Co., Ltd., Shanghai, 201506, China. anqi@king-cell.com.ORCID http://orcid.org/0000-0002-6444-7157
Jianmin JiangKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China. jmjiang@cdc.zj.cn.ORCID http://orcid.org/0000-0003-3563-4006
Hanping ZhuKey Lab of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, 310051, China. hpzhu@cdc.zj.cn.ORCID http://orcid.org/0000-0002-3204-3422
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
ChiropteraCoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralSevere acute respiratory syndrome-related coronavirusAnimalsBetacoronavirusChlorocebus aethiopsCOVID-19HumansSARS-CoV-2Vero Cells
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.